SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
19.26
-0.58 (-2.92%)
At close: May 29, 2026, 4:00 PM EDT
18.89
-0.37 (-1.92%)
After-hours: May 29, 2026, 4:55 PM EDT
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $643.8 million as of May 29, 2026.
Market Cap
643.80M
Enterprise Value
537.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.26
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $643.80M, an increase of 26.09%. That is a compound annual growth rate of 114.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 663.18M | -1.64% |
| May 27, 2026 | 674.21M | -2.18% |
| May 26, 2026 | 689.26M | -1.06% |
| May 22, 2026 | 696.61M | -5.49% |
| May 21, 2026 | 737.06M | 0.73% |
| May 20, 2026 | 731.71M | 3.25% |
| May 19, 2026 | 708.64M | -4.68% |
| May 18, 2026 | 743.41M | -4.18% |
| May 15, 2026 | 775.83M | -4.37% |
| May 14, 2026 | 811.26M | 1.89% |
| May 13, 2026 | 796.22M | -1.33% |
| May 12, 2026 | 806.92M | 1.60% |
| May 11, 2026 | 794.21M | 1.50% |
| May 8, 2026 | 782.52M | -7.80% |
| May 7, 2026 | 848.70M | 1.34% |
| May 6, 2026 | 837.50M | 2.64% |
| May 5, 2026 | 815.94M | - |
| May 4, 2026 | 815.94M | 1.79% |
| May 1, 2026 | 801.57M | 4.53% |
| Apr 30, 2026 | 766.81M | 3.66% |
| Apr 29, 2026 | 739.73M | -3.78% |
| Apr 28, 2026 | 768.81M | -2.75% |
| Apr 27, 2026 | 790.54M | 0.55% |
| Apr 24, 2026 | 786.19M | -0.47% |
| Apr 23, 2026 | 789.87M | -3.51% |
| Apr 22, 2026 | 818.62M | 0.16% |
| Apr 21, 2026 | 817.28M | -0.29% |
| Apr 20, 2026 | 819.62M | -1.68% |
| Apr 17, 2026 | 833.66M | -0.36% |
| Apr 16, 2026 | 836.67M | 1.21% |
| Apr 15, 2026 | 826.64M | 0.86% |
| Apr 14, 2026 | 819.62M | 2.72% |
| Apr 13, 2026 | 797.89M | 15.04% |
| Apr 10, 2026 | 693.60M | -2.21% |
| Apr 9, 2026 | 709.31M | -4.50% |
| Apr 8, 2026 | 742.74M | 5.46% |
| Apr 7, 2026 | 704.30M | -6.98% |
| Apr 6, 2026 | 757.11M | 0.85% |
| Apr 2, 2026 | 750.76M | -8.10% |
| Apr 1, 2026 | 816.95M | -5.67% |
| Mar 31, 2026 | 866.08M | 10.87% |
| Mar 30, 2026 | 781.18M | 3.36% |
| Mar 27, 2026 | 755.77M | -10.28% |
| Mar 26, 2026 | 842.35M | 0.25% |
| Mar 25, 2026 | 840.27M | 6.23% |
| Mar 24, 2026 | 790.96M | -9.91% |
| Mar 23, 2026 | 877.91M | 1.35% |
| Mar 20, 2026 | 866.25M | 1.13% |
| Mar 19, 2026 | 856.59M | -4.07% |
| Mar 18, 2026 | 892.91M | -1.47% |
| Mar 17, 2026 | 906.23M | 0.37% |
| Mar 16, 2026 | 902.90M | 2.07% |
| Mar 13, 2026 | 884.58M | 0.49% |
| Mar 12, 2026 | 880.25M | -2.51% |
| Mar 11, 2026 | 902.90M | 1.04% |
| Mar 10, 2026 | 893.57M | -1.11% |
| Mar 9, 2026 | 903.57M | 1.65% |
| Mar 6, 2026 | 888.91M | 0.98% |
| Mar 5, 2026 | 880.25M | -0.97% |
| Mar 4, 2026 | 888.91M | -0.26% |
| Mar 3, 2026 | 891.24M | 0.07% |
| Mar 2, 2026 | 890.57M | -4.54% |
| Feb 27, 2026 | 932.89M | -1.23% |
| Feb 26, 2026 | 944.55M | -2.68% |
| Feb 25, 2026 | 970.54M | -0.55% |
| Feb 24, 2026 | 975.87M | -0.20% |
| Feb 23, 2026 | 977.87M | 0.10% |
| Feb 20, 2026 | 976.87M | -1.21% |
| Feb 19, 2026 | 988.86M | 4.14% |
| Feb 18, 2026 | 949.55M | 2.93% |
| Feb 17, 2026 | 922.56M | -1.88% |
| Feb 13, 2026 | 940.22M | 2.62% |
| Feb 12, 2026 | 916.23M | -0.18% |
| Feb 11, 2026 | 917.89M | -1.01% |
| Feb 10, 2026 | 927.22M | 6.30% |
| Feb 9, 2026 | 872.25M | 70.84% |
| Feb 6, 2026 | 510.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 764.02M |
| Relmada Therapeutics | 752.05M |
| Alto Neuroscience | 738.21M |
| Allogene Therapeutics | 731.73M |
| Design Therapeutics | 712.01M |
| Tenax Therapeutics | 705.36M |
| Solid Biosciences | 677.33M |
| Crescent Biopharma | 676.21M |